{"id":"https://openalex.org/W3202228319","doi":"https://doi.org/10.2174/9789811464454121050004","title":"HIV-1 Genotypic Drug Resistance Testing and Next-Generation Sequencing","display_name":"HIV-1 Genotypic Drug Resistance Testing and Next-Generation Sequencing","publication_year":2021,"publication_date":"2021-10-03","ids":{"openalex":"https://openalex.org/W3202228319","doi":"https://doi.org/10.2174/9789811464454121050004","mag":"3202228319"},"language":"en","primary_location":{"id":"doi:10.2174/9789811464454121050004","doi":"https://doi.org/10.2174/9789811464454121050004","is_oa":false,"landing_page_url":"https://doi.org/10.2174/9789811464454121050004","pdf_url":null,"source":{"id":"https://openalex.org/S4210202022","display_name":"Frontiers in clinical drug research. HIV","issn_l":"2352-5916","issn":["2352-5916","2468-0397"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Clinical Drug Research: HIV","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028900793","display_name":"Binhua Liang","orcid":"https://orcid.org/0000-0002-1108-6407","observed_orcids":["https://orcid.org/0000-0002-1108-6407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Binhua Liang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077891098","display_name":"Melanie C. M. Murray","orcid":"https://orcid.org/0000-0001-9538-2758","observed_orcids":["https://orcid.org/0000-0001-9538-2758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie Murray","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066794848","display_name":"Sampathkumar Raghavan","orcid":"https://orcid.org/0000-0003-3500-9083","observed_orcids":["https://orcid.org/0000-0003-3500-9083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raghavan Sampathkumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074922265","display_name":"Ma Luo","orcid":"https://orcid.org/0000-0002-9827-4071","observed_orcids":["https://orcid.org/0000-0002-9827-4071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ma Luo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0782,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.81304665,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"39","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.828000009059906},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.734000027179718},{"id":"https://openalex.org/keywords/genotypic-drug-resistance-testing","display_name":"genotypic drug resistance testing","score":0.9010000228881836},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9549999833106995},{"id":"https://openalex.org/keywords/sequencing-errors","display_name":"sequencing errors","score":0.6779999732971191},{"id":"https://openalex.org/keywords/quality-assurance","display_name":"quality assurance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/bioinformatics","display_name":"bioinformatics","score":0.6919999718666077},{"id":"https://openalex.org/keywords/human-leukocyte-antigen","display_name":"human leukocyte antigen","score":0.8899999856948853},{"id":"https://openalex.org/keywords/host-factors","display_name":"host factors","score":0.703000009059906},{"id":"https://openalex.org/keywords/hiv-surveillance","display_name":"HIV surveillance","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.617238461971283},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.6025511026382446},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.575579822063446},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5360612869262695},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5102977752685547},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.45313069224357605},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3795546889305115},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3680771291255951},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.26408547163009644},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24439364671707153},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1146792471408844},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.10989883542060852},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.097715824842453}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/9789811464454121050004","doi":"https://doi.org/10.2174/9789811464454121050004","is_oa":false,"landing_page_url":"https://doi.org/10.2174/9789811464454121050004","pdf_url":null,"source":{"id":"https://openalex.org/S4210202022","display_name":"Frontiers in clinical drug research. HIV","issn_l":"2352-5916","issn":["2352-5916","2468-0397"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Clinical Drug Research: HIV","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4283643929","https://openalex.org/W3033664814","https://openalex.org/W3168063149","https://openalex.org/W4403948027","https://openalex.org/W4309754203","https://openalex.org/W2951983324","https://openalex.org/W2964526811","https://openalex.org/W978228178","https://openalex.org/W3025465733","https://openalex.org/W4402526358"],"abstract_inverted_index":{"The":[0],"emergence":[1],"and":[2,23,27,47,56,67,93,99,131,139,170,184],"spread":[3],"of":[4,41,102,114,119,128,136,208],"HIV":[5,69,78,103,120],"drug":[6],"resistance":[7],"(DR)":[8],"is":[9,60],"threatening":[10],"the":[11,30,39,106,148,155,158,190,195,199,206],"global":[12],"advances":[13],"gained":[14],"from":[15],"antiretroviral":[16],"therapy":[17],"(ART)":[18],"in":[19,50,105,116,179],"suppressing":[20],"HIV-1":[21,42,149,164],"infection":[22],"reducing":[24],"AIDS-related":[25],"morbidity":[26],"mortality":[28],"over":[29],"last":[31,107],"decade.":[32,108],"Next-generation":[33],"sequencing":[34,49,124],"(NGS)":[35],"has":[36,87],"fundamentally":[37],"altered":[38],"landscape":[40],"DR":[43,70,79,104,121,151,165],"testing":[44,152],"through":[45],"widely":[46],"deep":[48],"a":[51,112],"much":[52],"more":[53],"cost":[54],"effective":[55],"rapid":[57],"manner.":[58],"NGS":[59,86,110,129,160],"improving":[61],"our":[62],"ability":[63],"to":[64,83],"understand,":[65],"diagnose,":[66],"prevent":[68],"by":[71,91],"accurately":[72],"identifying":[73],"low":[74],"abundant":[75],"(<":[76],"20%)":[77],"variants":[80],"(LADRVs)":[81],"relevant":[82],"ART":[84,187],"outcomes.":[85,188],"been":[88],"increasingly":[89],"adopted":[90],"research":[92],"clinical":[94,100],"laboratories":[95],"for":[96,163],"research,":[97],"surveillance,":[98],"monitoring":[101],"However,":[109],"faces":[111],"number":[113],"limitations":[115],"its":[117,180],"application":[118],"testing,":[122],"including":[123,198],"error":[125],"management,":[126],"standardization":[127],"procedures":[130],"instruments,":[132],"external":[133],"quality":[134],"assurance":[135],"laboratories,":[137],"computational":[138],"bioinformatics":[140],"challenges.":[141],"In":[142,172,189],"this":[143],"chapter,":[144],"we":[145,174,192],"will":[146,175,193],"review":[147,177,194],"genotypic":[150],"methods":[153],"with":[154],"focus":[156],"on":[157,186],"main":[159],"platforms":[161],"available":[162],"diagnosis,":[166],"their":[167],"characteristics,":[168],"applications,":[169],"limitations.":[171],"addition,":[173],"systematically":[176],"LADRV":[178],"distribution,":[181],"prevalence,":[182],"mechanism,":[183],"impact":[185],"end,":[191],"host":[196],"factors,":[197],"human":[200],"leukocyte":[201],"antigen":[202],"(HLA),":[203],"which":[204],"effects":[205],"efficacy":[207],"ART.":[209]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-10-11T00:00:00"}